https://www.nejm.org/doi/pdf/10.1056/NEJMoa2306441
0
0
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions | NEJM - nejm.org
10/21/23 at 2:30pm
Organization
nejm.org
Author
nejm.org
13 words
0
Comments
You are the first to view
Create an account or login to join the discussion